Intro To PCOS Flashcards
WHY PCOS?
arguable most prev. medical condition in women
What systemic metabolic manifestations are associated with multiple symptomatology? (9)
endocrine, gynaecological, diabetic, dermatological, eating
disorder, psychiatry - complex
- life long impact from IR
-Obesity has bigger impact on PCOS compared to normal esp IR
Polycystic Ovaries (5)
-increased numbers (>20) of small antral follicles (2-9mm)
= dependent on quality : visible on high quality transvaginal u/s transducers (arranged as necklace of pearls)
There is a disorder of follicle growth at all stages:
– Possibly inc. proportion of primordial follicles & inc. no. of activated (primary) follicles
– Arrested antral follicle growth before they mature
– Lower rates of atresia » antral follicles persist (visible on u/s)
-some cases there is a failure of df selection and therefore anovulation infertility
why are they called cysts?
They are arrested follicles not cysts - just named due to their initial discovery but these differ from ovarian cysts.
PCOS discovery (2)
Described as obesity, hirsutism and anovulation in the presence of bilaterally enlarged sclerocystic (hardened) ovaries
(1935) - Stein + Leventhal
Diagnosis then and now (2)
Then: visuall - biopsies, surgeries, deaths (post mortem)
now: ultrasounds +(transvaginal probe)
spectrum of presentation =Lack of consensus for definition
- now measured using rotterdam criteria POST-EXCLUSION of other disorders
disorders that mimic PCOS/ diagnosis of exclusion: (3)
– Non-classical adrenal hyperplasia (most common is deficiency of 21-hydroxylase → ↑17-hydroxyprogesterone & androgens = PCOS Symp’s)
– Hyperprolactinemia, thyroid disease, Cushing’s syndrome
– Ovarian hyperthecosis (very rare) - nests of luteinized theca cells
Rotterdam Criteria : Diagnosis - need 2 out of 3 criteria (6)
-polycystic ovaries
-Hyper-androgenism
-Ovulatory dysfunction
Polycystic Ovaries: (20 or more follicles measuring 2-9mm diameter and/or increased ovarian volume >10ml in either ovary & no DF >10mm)
-Technique and equipment dependent. T/V imaging not always appropriate
Hyper-androgenism: (clinical (acne/ hair)/biochemical evidence) Assays not
standardized across labs; normative data not clearly defined; clinical hyperandrogenism difficult to quantify; ethnicity
Ovulatory Dysfunction: (Oligomenorrhea/anovulation): Frequent bleeding
<21d or infrequent bleeding >35d.
-To confirm ovulation serum progesterone level at mid-luteal phase (d21-22) of cycle (values ≥7ng/ml needed for regular luteal function)
Polycystic ovary morphology (PCOM) (3)
NORMAL: ≤5 follicles in an ovary with a small amount of stroma early follicular mid-follicular ovulation - then DF emerging + shrunk other follciles
ANOVULATORY PCO: ≥ 20 follicles, 2-9mm diameter arranged necklace follicles around enlarged core of dense stroma - ovarian volume >10mls, with NO df
OVULATORY PCO: scan early = anov. , continue scanning during cycle = emergence of DF but instead of others shrinking + dying - they persist
Refinement of Rotterdam criteria - phenotypes (7)
(table)
A: hyperandro., OD, PCOM
B: hyperandro., OD,
C:hyperandro., PCOM
D: OD, PCOM
- Phenotypes A&B are considered classic PCOS → (2/3 of cases) + also common in these phenotypes is BMI and metabolic syndrome
- Phenotype C (ovulatory PCOS) → BMI is often normal, but if BMI increases can alter phenotypic presentation
- Phenotype D (normoandrogenic PCOS) includes chronic anovulation + PCOM but normal serum androgens and no HA
Anovulation (4)
- Most women with PCOM probably have regular/almost regular cycles
- Most women with PCOS and cycle problems have oligomenorrhoea
- Main difference between ov and anov is also the level of IR - IR tps them into Anov
- Adult rhesus macaques fed western style diet (high fat/sugar) & exposed to chronically elevated T from pre-puberty to menopause altered small AF no.’s, morphology and transcriptome
What are the candidates for follicle arrest? (4)
– androgens
– intra-follicular inhibitors eg AMH
– defect in apoptosis (follicles that don’t shrink + die)
– dysregulated gonadotrophin secretion (both FSH and LH)
Prevalence of PCO (9)
PCO present in
– 32% of patients with amenorrhoea
– 87% with oligomenorrhoea
– 87% with hirsutism and regular cycles
– 75% of bulimics?
– 22% of ‘normal’ population
-most common cause of anovulatory infertility-73%
Numerous studies since on prevalence:
– PCOM approx. 20%
– PCOS 5-10% depending on definition
PCOS prevalence across populations (4)
- PCOS presentation in European pop differs from US pop
- US: variability seen between Hispanic , African-American + White pop.’s
- East Asian population w/ PCOS have ↓ BMI + hirsutism compared to other population
- South Asian populations have greater IR ; metabolic sequelae and obesity cf to other populations
Aetiology- genetics (8)
- Familial aggregation
– Sisters more likely to be affected
– first-degree relatives have higher rates of metabolic abnormalities (including insulin resistance, decreased beta-cell function etc)
– Male relatives of women with PCOS increased prevalence of metabolic syndrome & obesity compared to general US male population - Monozygotic twins twice as likely to both have PCOS than
dizygotic. - common finding of raised androgen led to belief that PCOS is caused by an inherited disorder -most likely in the steroid biosynthetic pathway
- Many candidate genes were investigated: all ‘obvious’ ones ruled out
- Complex polygenic disease – involves subtle interaction with environmental factors (intra- & extra-uterine)